Molecular biology of esophageal squamous cell carcinoma.

Esophageal squamous cell carcinoma (ESCC) is the predominant histologic subtype of esophageal cancer and characterized by high mortality rate and geographic differences in incidence. With the advances in the field of molecular biology, our understanding of the pathogenesis, epidemiology and behavior of ESCC continues to evolve. The recent development includes research in etiopathogenesis (viruses and cancer susceptibility genes), keratins, tumor related genes (oncogenes, tumor suppressor genes, genes involved in metastasis and apoptosis genes), proliferation-related factors (nuclear proteins, flow cytometry/morphometry, argyrophilic nucleolar organizer region) and factors related to metastases (cell adhesion molecules and enzymes related to degradation of extracellular matrix). There are ranges of molecular techniques potentially available to complement the traditional approaches in the management of ESCC. On the other hand, critics are needed in the interpretation and translation of these research findings from laboratories to clinics. Further investigations, education and collaborations between the various scientific and clinical disciplines are important to successful application of these molecular findings aiming at improving management of patients with ESCC.

[1]  G. Plowman,et al.  Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Tsujitani,et al.  Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma. , 1997, Oncology.

[3]  S. Groshen,et al.  High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach , 1997, Oncogene.

[4]  M. Oka,et al.  CYFRA 21‐1 is a useful marker for esophageal squamous cell carcinoma , 1997, Cancer.

[5]  Y. Tachimori,et al.  Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. , 1997, Japanese journal of clinical oncology.

[6]  M. Imamura,et al.  Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. , 1991, Cancer research.

[7]  K. Chow,et al.  p53 gene alternation in squamous cell carcinoma of the esophagus detected by PCR-cold SSCP analysis. , 1998, Proceedings of the National Science Council, Republic of China. Part B, Life sciences.

[8]  R. Metcalf,et al.  Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. , 1991, Cancer research.

[9]  M. Redston,et al.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival. , 1998, Molecular pathology : MP.

[10]  A. Rustgi,et al.  The association of Epstein-Barr virus DNA with esophageal squamous cell carcinoma. , 1996, Oncogene.

[11]  B. Nordlinger,et al.  Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  A. Rustgi,et al.  Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines. , 1997, Cancer letters.

[13]  Patricia L. Blount,et al.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  M. Toi,et al.  Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer , 1991, Cancer.

[15]  M. Younes,et al.  Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  H. Sakamoto,et al.  Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas. , 1993, Biochemical and biophysical research communications.

[17]  P. Validire,et al.  Human papillomavirus infection in esophageal squamous‐cell carcinoma in western countries , 1992, International journal of cancer.

[18]  Y. Sasaguri,et al.  Production onf matrix metalloproteinase‐2 and metalloproteinase‐3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study , 1992, Cancer.

[19]  R. Hardwick,et al.  Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[20]  C. Chang,et al.  Expression of multiple oncogenes in human esophageal carcinomas. , 1994, Cancer investigation.

[21]  R. White,et al.  MCC, a candidate familial polyposis gene in 5q.21, shows frequent allele loss in colorectal and lung cancer. , 1991, Oncogene.

[22]  N. Day,et al.  Oesophageal cancer in never‐smokers and never‐drinkers , 1995, International journal of cancer.

[23]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[24]  M. Feith,et al.  Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma , 1998, Cancer.

[25]  M. Imamura,et al.  Allelotype analysis of esophageal squamous cell carcinoma. , 1994, Cancer research.

[26]  S. Bhambhani,et al.  Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer. , 1998, Indian journal of experimental biology.

[27]  M. Saegusa,et al.  Expression of bcl‐2 protein in esophageal squamous cell carcinomas and its association with lymph node metastasis , 1997, Cancer.

[28]  P. I. Reed,et al.  The Changing Incidence of Oesophageal Cancer , 1993, Endoscopy.

[29]  A. van der Gaast,et al.  13-cis-retinoic acid and alpha-interferon in advanced squamous cell cancer of the oesophagus. , 1997, European journal of cancer.

[30]  A. Rustgi,et al.  MTS-1 (CDKN2) tumor suppressor gene deletions are a frequent event in esophagus squamous cancer and pancreatic adenocarcinoma cell lines. , 1995, Oncogene.

[31]  T. Sugimura,et al.  High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. , 1989, Cancer research.

[32]  T. Kawano,et al.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility. , 1997, Journal of clinical gastroenterology.

[33]  A. Khurshid,et al.  Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma. , 1998, JPMA. The Journal of the Pakistan Medical Association.

[34]  A. Rustgi,et al.  Human cyclin D1 oncogene and esophageal squamous cell carcinoma , 1995, Cancer.

[35]  S. Seeber,et al.  Prognostic significance of cyclin D1 in esophageal squamous cell carcinoma patients treated with surgery alone or combined therapy modalities , 1999, International journal of cancer.

[36]  M. Kitajima,et al.  Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  J. Wong,et al.  Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness? , 1997, European journal of cancer.

[38]  Y. Sasaguri,et al.  Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. , 1992, Cancer.

[39]  T. Sugimura,et al.  Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. , 1994, Biochemical and biophysical research communications.

[40]  J. Nesland,et al.  Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas. , 1995, Anticancer research.

[41]  Janusz Jankowski,et al.  Sequential changes in cadherin‐catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma , 1998 .

[42]  J. Ferlay,et al.  Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden , 1993, International journal of cancer.

[43]  S. Tsao,et al.  Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. , 1997, Human pathology.

[44]  R. Ralhan,et al.  High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  S. Wilczynski,et al.  Human papillomavirus (HPV) in head and neck cancer , 1997, Cancer.

[46]  M. Yano,et al.  CYP1A1 CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous‐cell carcinoma of the esophagus , 1997, International journal of cancer.

[47]  K. Syrjänen,et al.  Demonstration of human papillomavirus (HPV) type 30 in esophageal squamous‐cell carcinomas by in situ hybridization , 1993, International journal of cancer.

[48]  R. Chetty,et al.  Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma. , 1997, Molecular pathology : MP.

[49]  M. Kitajima,et al.  Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  H. Hausen,et al.  Human papillomaviruses. , 1994, Annual review of microbiology.

[51]  R. Odze,et al.  Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. , 1997, Human pathology.

[52]  J. Yokota,et al.  AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.

[53]  J. Wong,et al.  Measurement of extent of spread of oesophageal squamous carcinoma by serial sectioning. , 1996, Journal of clinical pathology.

[54]  H. Sasano,et al.  Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification , 1994, Cancer.

[55]  Y. Doki,et al.  E-Cadherin and α-Catenin Expression in Human Esophageal Cancer , 1994 .

[56]  E. Thiel,et al.  Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. , 1996, Journal of molecular medicine.

[57]  H. Gabbert,et al.  Prognostic significance of urokinase-type plasminogen activator expression in squamous cell carcinomas of the esophagus. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  D. Lin,et al.  Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[59]  K. Orita,et al.  Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy. , 1995, Anticancer research.

[60]  M. Monden,et al.  Decreased E‐cadherin expression is associated with haematogenous recurrence and poor prognosis in patients with squamous cell carcinoma of the oesophagus , 1996, The British journal of surgery.

[61]  J. Icenogle,et al.  Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska natives , 1997, International journal of cancer.

[62]  M. Rugge,et al.  p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[63]  D. Birnbaum,et al.  Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1. , 1995, British Journal of Cancer.

[64]  R. Willers,et al.  The prognostic significance of tumour cell proliferation in squamous cell carcinomas of the oesophagus. , 1996, British Journal of Cancer.

[65]  N. Shimizu,et al.  Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas , 1989, Cancer.

[66]  K. Lam,et al.  Pathology of esophageal cancers: local experience and current insights. , 1997, Chinese medical journal.

[67]  S. Mori,et al.  Frequent loss of heterozygosity in the region including BRCA1 on chromosome 17q in squamous cell carcinomas of the esophagus. , 1994, Cancer research.

[68]  K. Lam,et al.  C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[69]  D. Rosenthal,et al.  Cell Adhesion Molecules , 1991, International journal of dermatology.

[70]  J. McKay,et al.  Matrix metalloproteinase‐1 is associated with poor prognosis in oesophageal cancer , 1998, The Journal of pathology.

[71]  Y. Yamashita,et al.  Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers. , 1998, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[72]  Y. Doki,et al.  Effect of cyclin D1 and associated proteins on proliferation of esophageal squamous cell carcinoma. , 1998, International journal of oncology.

[73]  K. Somers,et al.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.

[74]  M. Hollstein,et al.  p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[75]  S. Law,et al.  Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico‐pathological study and survival analysis of 70 patients , 1997, International journal of cancer.

[76]  Simon Law,et al.  The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients , 1999, American Journal of Gastroenterology.

[77]  T. Gansler,et al.  Differential Polymerase Chain Reaction Assay of Cyclin Dl Gene Amplification in Esophageal Carcinoma , 1994, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[78]  Y. Nimura,et al.  Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking , 1997, Cancer.

[79]  K. Sugimachi,et al.  Epstein-Barr virus-associated carcinomas of the esophagus and stomach. , 1994, Archives of pathology & laboratory medicine.

[80]  M. Hollstein,et al.  Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas , 1996, International journal of cancer.

[81]  K. Sugimachi,et al.  The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer. , 1995, European Journal of Surgical Oncology.

[82]  C. Fenoglio-Preiser,et al.  Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. , 1997, Human pathology.

[83]  Y. Sasaguri,et al.  Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. , 1993, British Journal of Cancer.

[84]  H. Yamamoto,et al.  Matrix metalloproteinase matrilysin (MMP-7) participates in the progression of human gastric and esophageal cancers. , 1998, International journal of oncology.

[85]  M. Sur,et al.  The role of the human papilloma virus in esophageal cancer , 1998, Pathology.

[86]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[87]  M. Imamura,et al.  p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[88]  R. Morgan,et al.  Human papillomavirus and oesophageal squamous cell carcinoma in the UK. , 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[89]  Y. Doki,et al.  Cytoplasmic β‐catenin in esophageal cancers , 1999 .

[90]  A. Burgess,et al.  The Sixth George Swanson Christie Memorial Lecture: Growth Factors And Their Receptors: New Opportunities For Cancer Treatment , 1994, Pathology.

[91]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[92]  H. Sasano,et al.  Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression. , 1993, Anticancer research.

[93]  C. D'Arrigo,et al.  Cell adhesion molecules in oesophageal epithelium. , 1994, Gut.

[94]  P. Dickens,et al.  Transient detection of antinuclear and anti-smooth muscle antibodies in hepatitis A virus infection. , 1995 .

[95]  T. McDaniel,et al.  Altered messenger RNA and unique mutational profiles of p53 and Rb in human esophageal carcinomas. , 1993, Cancer research.

[96]  H. Saya,et al.  The CD44 adhesion molecule and metastasis. , 1994, Critical reviews in oncogenesis.

[97]  M. Monden,et al.  Beta-catenin expression in human cancers. , 1996, The American journal of pathology.

[98]  R. Willers,et al.  bcl‐2 expression and prognosis in squamous‐cell carcinomas of the esophagus , 1996, International journal of cancer.

[99]  T. Walsh,et al.  Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy , 1994 .

[100]  I. Weinstein,et al.  Amplification and expression of the human cyclin D gene in esophageal cancer. , 1992, Cancer research.

[101]  P. V. van Helden,et al.  p53 and p16/CDKN2 gene mutations in esophageal tumors from a high‐incidence area in South Africa , 1998, International journal of cancer.

[102]  G. Yang,et al.  Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. , 1999, Carcinogenesis.

[103]  K. Hirokawa,et al.  Expression of the cyclin dependent kinase inhibitor p21WAF1/CIP1 in oesophageal squamous cell carcinomas , 1997, Virchows Archiv.

[104]  S. Hirohashi,et al.  Expression of E-Cadherin, α-Catenin, β-Catenin and Plakoglobin in Esophageal Carcinomas and Its Prognostic Significance , 1997 .

[105]  J. Wong,et al.  Prognostic implication of proliferative markers MIB‐1 and PC10 in esophageal squamous cell carcinoma , 1996, Cancer.

[106]  Patricia L. Blount,et al.  Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers. , 1991, Cancer research.

[107]  S. Seeber,et al.  Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[108]  H. Gabbert,et al.  Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[109]  M. Arima,et al.  Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers. , 1998, Oncology reports.

[110]  T. Hattori,et al.  Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. , 1995, The American journal of pathology.

[111]  L. Matrisian,et al.  Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts , 1986, Molecular and cellular biology.

[112]  Ruggero Montesano,et al.  Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review , 1996, International journal of cancer.

[113]  R. Poczatek,et al.  CD44 expression in dysplastic epithelium and squamous‐cell carcinoma of the esophagus , 1996, International journal of cancer.

[114]  L. Signorello,et al.  Life‐style factors and medical conditions in relation to esophageal cancer by histologic type in a low‐risk population , 1996, International journal of cancer.

[115]  S. J. Darnton,et al.  Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade. , 1996, Journal of clinical pathology.

[116]  M. Rugge,et al.  bcl‐2 and p53 immunophenotypes in pre‐invasive, early and advanced oesophageal squamous cancer , 1997, Histopathology.

[117]  M. Koike,et al.  Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa: Immunohistochemical analysis of Ki‐67 and p53 antigen in relation to histopathologic findings , 1996, Cancer.

[118]  Johannes Gerdes,et al.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation , 1983, International journal of cancer.

[119]  M. Saegusa,et al.  Absence of human papillomavirus genomic sequences detected by the polymerase chain reaction in oesophageal and gastric carcinomas in Japan. , 1997, Molecular pathology : MP.

[120]  M. Imamura,et al.  Analysis of gene amplification and overexpression in human esophageal‐carcinoma cell lines , 1994, International journal of cancer.

[121]  R. Veale,et al.  Amplification and expression of the TGF-α, EGF receptor and c-myc genes in four human oesophageal squamous cell carcinoma lines , 1993, Bioscience reports.

[122]  A. Niendorf,et al.  Expression and prognostic significance of immunoregulatory molecules in esophageal cancer , 1997, International journal of cancer.

[123]  Y. Ikeda,et al.  Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. , 1996, Annals of Thoracic Surgery.

[124]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[125]  E. Tahara,et al.  EGF and TGF‐α, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors , 1990 .

[126]  T. Aikou,et al.  Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus. , 1997, British Journal of Cancer.

[127]  R. Eddy,et al.  Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. , 1993, Oncogene.

[128]  M. Kaminishi,et al.  Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer. , 1998, Hepato-gastroenterology.

[129]  S. Tsao,et al.  Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation , 1997, International journal of cancer.

[130]  R. Giavazzi,et al.  Matrix metalloproteinase inhibition: a review of anti-tumour activity. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[131]  S. Maeda,et al.  Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study. , 1993, Asian Pacific journal of allergy and immunology.

[132]  M. Imamura,et al.  Multiple types of aberrations in the p16 (INK4a) and the p15(INK4b) genes in 30 esophageal squamous‐cell‐carcinoma cell lines , 1997, International journal of cancer.

[133]  K. Sugimachi,et al.  Correlation between reduced p21(WAF1/CIP1) expression and abnormal p53 expression in esophageal carcinomas. , 1997, International journal of oncology.

[134]  E. de Villiers,et al.  Papillomavirus in esophageal papillomas and carcinomas , 1999, International journal of cancer.

[135]  F. Grabellus,et al.  Expression of Bax, a pro‐apoptotic member of the Bcl‐2 family, in esophageal squamous cell carcinoma , 1997, International journal of cancer.

[136]  D. Hernandez-Verdun,et al.  The nucleolus and the nucleolar organizer regions , 1986, Biology of the cell.

[137]  A. Brichet,et al.  Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study. , 1996, The Annals of thoracic surgery.

[138]  A. West,et al.  Type 73 human papillomavirus in esophageal squamous cell carcinoma: A novel association , 1996, Cancer.

[139]  M. Furihata,et al.  Positive correlation between P27Kip1 expression and progression of human esophageal squamous cell carcinoma , 1998, International journal of cancer.

[140]  D. Skinner,et al.  Expression of ras oncogene p21 protein in esophageal squamous cell carcinoma , 1990, Journal of surgical oncology.

[141]  C. Fenoglio-Preiser,et al.  Detection of human papillomavirus in esophageal squamous cell carcinoma , 1996, Cancer.

[142]  W. Chen,et al.  Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[143]  L. Billingham,et al.  Expression of E-cadherin in oesophageal carcinomas from the UK and China: disparities in prognostic significance. , 1997, Journal of clinical pathology.

[144]  N. Muñoz Epidemiological Aspects of Oesophageal Cancer , 1993, Endoscopy.

[145]  G. Hannon,et al.  Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. , 1995, Human molecular genetics.

[146]  M. Posner,et al.  Apoptosis in esophageal cancer following induction chemoradiotherapy. , 1998, The Journal of surgical research.

[147]  D. Parkin,et al.  Patterns of Cancer in Five Continents , 1990, British Journal of Cancer.

[148]  C. Harris,et al.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[149]  Y. Doki,et al.  Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. , 1997, Carcinogenesis.

[150]  M. Furihata,et al.  Relationship between H-ras p21 product and p53 protein or high-risk human papillomaviruses in esophageal cancer from Kochi, Japan. , 1994, The American journal of gastroenterology.

[151]  J. Abraham,et al.  The MTS1 gene is frequently mutated in primary human esophageal tumors. , 1994, Oncogene.

[152]  E. de Villiers,et al.  An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China , 1999, International journal of cancer.

[153]  M. Cravo,et al.  High prevalence of human papillomavirus in squamous cell carcinoma and matched normal esophageal mucosa. Assessment by polymerase chain reaction , 1995, Cancer.

[154]  G. Thomas,et al.  Loss of heterozygosity on chromosome 9 and p16 (MTS1, CDKN2) gene mutations in esophageal cancers , 1997, International journal of cancer.

[155]  S. Fukushima,et al.  Prognostic significance of the MIB‐1 proliferation index for patients with squamous cell carcinoma of the esophagus , 1995, Cancer.

[156]  S. Mori,et al.  Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies. , 1992, Anticancer research.

[157]  S. Syrjänen,et al.  p53 overexpression and human papillomavirus (HPV) infection in oesophageal squamous cell carcinomas derived from a high-incidence area in China. , 1997, Anticancer research.

[158]  A. Marchetti,et al.  Cell cycle-related gene abnormalities and product expression in esophageal carcinoma. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[159]  Y. Naomoto,et al.  Suppressed apoptotic induction in esophageal squamous cell carcinomas expressing extensive p53 protein. , 1996, Japanese journal of clinical oncology.

[160]  S. Nishizuka,et al.  Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. , 1996, Cancer research.

[161]  Y. Yuasa,et al.  Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. , 1994, Cancer research.

[162]  M. Poljak,et al.  Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. , 1998, Human pathology.

[163]  S. Mori,et al.  Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. , 1994, Cancer research.

[164]  S. Kitano,et al.  Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer. , 1998, Oncology reports.

[165]  S. Law,et al.  Use of flow cytometry in the analysis of stage III squamous cell carcinoma of the oesophagus and its association with MIB-1. , 1996, Journal of Clinical Pathology.

[166]  L. Wang,et al.  No evidence for the amplifications of MDM2 and C-myc genes involved in the genetic susceptibility to esophageal cancer in a high-risk area of north China. , 1996, Cancer genetics and cytogenetics.

[167]  I. Pastan,et al.  Frequent expression of the tumor antigen cak1 in squamous‐cell carcinomas , 1992, International journal of cancer.

[168]  M. Pignatelli,et al.  The molecular histology of neoplasia: the role of the cadherin/catenin complex , 1997, Histopathology.

[169]  M. Rugge,et al.  p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma. , 1998, Molecular pathology : MP.

[170]  P. Chikhlikar,et al.  Clinical significance of p53, nm23, and bcl‐2 in T3–4N1M0 oesophageal carcinoma: An immunohistochemical approach , 1997, Journal of surgical oncology.

[171]  K. Nooter,et al.  No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area. Rotterdam Oesophageal Tumour Study Group. , 1997, European Journal of Cancer.

[172]  Y. Kitagawa,et al.  Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. , 1991, Cancer research.

[173]  H. Sakamoto,et al.  Amplified genes in cancer in upper digestive tract. , 1993, Seminars in cancer biology.

[174]  S. J. Darnton,et al.  Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. , 1995, Journal of clinical pathology.

[175]  T. Akiyama,et al.  Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumors , 1987, Virchows Archiv. B, Cell pathology including molecular pathology.

[176]  M. Tsao,et al.  ras mutation and expression of the ras‐regulated genes osteopontin and cathepsin L in human esophageal cancer , 1997, International journal of cancer.

[177]  G. Yang,et al.  Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high‐risk area in northern China , 1997, International journal of cancer.

[178]  H. Sabe,et al.  Expression of the c-myc gene in human gastrointestinal malignancies. , 1987, Biochemical and biophysical research communications.

[179]  M. Lung,et al.  p16 tumor suppressor gene mutations in Chinese esophageal carcinomas in Hong Kong. , 1997, Cancer letters.

[180]  M. Furihata,et al.  Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. , 1998, British Journal of Cancer.

[181]  S. Yoshida,et al.  Association of p53 protein expression with responses and survival of patients with locally advanced esophageal carcinoma treated with chemoradiotherapy. , 1996, Japanese journal of clinical oncology.

[182]  F. Puglisi,et al.  Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus. , 1996, Journal of clinical pathology.